9月 2023, <>
英文版
加利福尼亚州红木城,09年2023月31日(环球通讯社)--Soleno Therapeutics,Inc.(Soleno)(纳斯达克股票代码:SLNO)...查看全文
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-028521 Size: 8 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-028522 Size: 8 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-012501 Size: 24 KB 网页链接
$Soleno Therapeutics(SLNO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-23-140790 Act: 34 Size: 27 KB 网页链接
$Soleno Therapeutics(SLNO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-019752 Act: 34 Size: 6 MB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 2.02, 3.02, and 9.01 Accession Number: 0001193125-23-139402 Act: 34 Size: 223 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-23-134588 Act: 34 Size: 169 KB 网页链接
$Soleno Therapeutics(SLNO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-23-108306 Act: 34 Size: 735 KB 网页链接
$Soleno Therapeutics(SLNO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-23-101135 Act: 34 Size: 1 MB 网页链接
$Soleno Therapeutics(SLNO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-23-091029 Act: 34 Size: 1 MB 网页链接